Systemic postganglionic adrenergic studies do not distinguish parkinson's disease from multiple system atrophy

Axel Lipp, Paola Sandroni, Phillip Anson Low

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Multiple system atrophy (MSA) affects the preganglionic adrenergic neuron and Parkinson's disease (PD) involves the postganglionic counterpart. Widespread postganglionic denervation should result in denervation supersensitivity and a failure of the axon to release norepinephrine (NE). We examined if pharmacological dissection of the adrenergic neuron can distinguish between MSA and PD. Method: We measured blood pressure, heart rate, and plasma NE responses to direct (phenylephrine) and indirect (tyramine) acting adrenergic agonists in 15 patients with probable MSA, 16 patients with idiopathic PD, and 16 age- and gender-matched controls. Results: Baroreflex sensitivity was impaired in MSA and intact in PD. Pressor responses to phenylephrine (direct acting) were higher in MSA (p < 0.01) and PD patients (p = 0.04) than in controls. Blood pressure responses to tyramine (indirect acting) were increased in MSA only (p < 0.01). Tyramine increased plasma catecholamine levels in all groups with no significant differences between groups. Conclusion: There is denervation supersensitivity in PD patients that is, however, insufficient to shift the dose-response curve to the left. The excessive pressor responses to both tyramine and phenylephrine in MSA are due to baroreflex failure. We conclude that this diagnostic approach lacks sufficient sensitivity to differentiate PD and MSA.

Original languageEnglish (US)
Pages (from-to)15-19
Number of pages5
JournalJournal of the Neurological Sciences
Volume281
Issue number1-2
DOIs
StatePublished - Jun 15 2009

Fingerprint

Multiple System Atrophy
Adrenergic Agents
Parkinson Disease
Tyramine
Phenylephrine
Denervation
Adrenergic Neurons
Baroreflex
Norepinephrine
Blood Pressure
Adrenergic Agonists
Catecholamines
Axons
Dissection
Heart Rate
Pharmacology

Keywords

  • Autonomic
  • Baroreflex
  • Denervation supersensitivity
  • MSA
  • PD
  • Phenylephrine
  • Tyramine

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Systemic postganglionic adrenergic studies do not distinguish parkinson's disease from multiple system atrophy. / Lipp, Axel; Sandroni, Paola; Low, Phillip Anson.

In: Journal of the Neurological Sciences, Vol. 281, No. 1-2, 15.06.2009, p. 15-19.

Research output: Contribution to journalArticle

@article{1b10a5c7613b41d5bbda111e086bd2cc,
title = "Systemic postganglionic adrenergic studies do not distinguish parkinson's disease from multiple system atrophy",
abstract = "Background: Multiple system atrophy (MSA) affects the preganglionic adrenergic neuron and Parkinson's disease (PD) involves the postganglionic counterpart. Widespread postganglionic denervation should result in denervation supersensitivity and a failure of the axon to release norepinephrine (NE). We examined if pharmacological dissection of the adrenergic neuron can distinguish between MSA and PD. Method: We measured blood pressure, heart rate, and plasma NE responses to direct (phenylephrine) and indirect (tyramine) acting adrenergic agonists in 15 patients with probable MSA, 16 patients with idiopathic PD, and 16 age- and gender-matched controls. Results: Baroreflex sensitivity was impaired in MSA and intact in PD. Pressor responses to phenylephrine (direct acting) were higher in MSA (p < 0.01) and PD patients (p = 0.04) than in controls. Blood pressure responses to tyramine (indirect acting) were increased in MSA only (p < 0.01). Tyramine increased plasma catecholamine levels in all groups with no significant differences between groups. Conclusion: There is denervation supersensitivity in PD patients that is, however, insufficient to shift the dose-response curve to the left. The excessive pressor responses to both tyramine and phenylephrine in MSA are due to baroreflex failure. We conclude that this diagnostic approach lacks sufficient sensitivity to differentiate PD and MSA.",
keywords = "Autonomic, Baroreflex, Denervation supersensitivity, MSA, PD, Phenylephrine, Tyramine",
author = "Axel Lipp and Paola Sandroni and Low, {Phillip Anson}",
year = "2009",
month = "6",
day = "15",
doi = "10.1016/j.jns.2009.03.006",
language = "English (US)",
volume = "281",
pages = "15--19",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Systemic postganglionic adrenergic studies do not distinguish parkinson's disease from multiple system atrophy

AU - Lipp, Axel

AU - Sandroni, Paola

AU - Low, Phillip Anson

PY - 2009/6/15

Y1 - 2009/6/15

N2 - Background: Multiple system atrophy (MSA) affects the preganglionic adrenergic neuron and Parkinson's disease (PD) involves the postganglionic counterpart. Widespread postganglionic denervation should result in denervation supersensitivity and a failure of the axon to release norepinephrine (NE). We examined if pharmacological dissection of the adrenergic neuron can distinguish between MSA and PD. Method: We measured blood pressure, heart rate, and plasma NE responses to direct (phenylephrine) and indirect (tyramine) acting adrenergic agonists in 15 patients with probable MSA, 16 patients with idiopathic PD, and 16 age- and gender-matched controls. Results: Baroreflex sensitivity was impaired in MSA and intact in PD. Pressor responses to phenylephrine (direct acting) were higher in MSA (p < 0.01) and PD patients (p = 0.04) than in controls. Blood pressure responses to tyramine (indirect acting) were increased in MSA only (p < 0.01). Tyramine increased plasma catecholamine levels in all groups with no significant differences between groups. Conclusion: There is denervation supersensitivity in PD patients that is, however, insufficient to shift the dose-response curve to the left. The excessive pressor responses to both tyramine and phenylephrine in MSA are due to baroreflex failure. We conclude that this diagnostic approach lacks sufficient sensitivity to differentiate PD and MSA.

AB - Background: Multiple system atrophy (MSA) affects the preganglionic adrenergic neuron and Parkinson's disease (PD) involves the postganglionic counterpart. Widespread postganglionic denervation should result in denervation supersensitivity and a failure of the axon to release norepinephrine (NE). We examined if pharmacological dissection of the adrenergic neuron can distinguish between MSA and PD. Method: We measured blood pressure, heart rate, and plasma NE responses to direct (phenylephrine) and indirect (tyramine) acting adrenergic agonists in 15 patients with probable MSA, 16 patients with idiopathic PD, and 16 age- and gender-matched controls. Results: Baroreflex sensitivity was impaired in MSA and intact in PD. Pressor responses to phenylephrine (direct acting) were higher in MSA (p < 0.01) and PD patients (p = 0.04) than in controls. Blood pressure responses to tyramine (indirect acting) were increased in MSA only (p < 0.01). Tyramine increased plasma catecholamine levels in all groups with no significant differences between groups. Conclusion: There is denervation supersensitivity in PD patients that is, however, insufficient to shift the dose-response curve to the left. The excessive pressor responses to both tyramine and phenylephrine in MSA are due to baroreflex failure. We conclude that this diagnostic approach lacks sufficient sensitivity to differentiate PD and MSA.

KW - Autonomic

KW - Baroreflex

KW - Denervation supersensitivity

KW - MSA

KW - PD

KW - Phenylephrine

KW - Tyramine

UR - http://www.scopus.com/inward/record.url?scp=67349221742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349221742&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2009.03.006

DO - 10.1016/j.jns.2009.03.006

M3 - Article

C2 - 19345959

AN - SCOPUS:67349221742

VL - 281

SP - 15

EP - 19

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -